ACLY: A biomarker of recurrence in breast cancer
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (9) , 153076
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572604, 81773756, 81874071)
- Science and Technology Department of Sichuan Province (14ZC1793)
This publication has 30 references indexed in Scilit:
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approachesCancer Letters, 2014
- Personalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2JAMA Surgery, 2014
- Cytosolic functions of MORC2 in lipogenesis and adipogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38Molecular Cancer Therapeutics, 2013
- Acetylation Stabilizes ATP-Citrate Lyase to Promote Lipid Biosynthesis and Tumor GrowthMolecular Cell, 2013
- ATP-citrate lyase: A mini-reviewBiochemical and Biophysical Research Communications, 2012
- CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC CellsGastroenterology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- ATP Citrate Lyase: Activation and Therapeutic Implications in Non–Small Cell Lung CancerCancer Research, 2008
- ATP citrate lyase is an important component of cell growth and transformationOncogene, 2005